Špela Gubič

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum Stress

Top Venues

Medicinal research reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Špela Gubič, Louise Antonia Hendrickx, Xiaoyi Shi, Žan Toplak, Štefan Možina, Kenny M Van Theemsche, Ernesto Lopes Pinheiro-Junior, Steve Peigneur, Alain J Labro, Luis A Pardo, Jan Tytgat, Tihomir Tomašič, Lucija Peterlin Mašič
Correction: Gubič et al. Design of New Potent and Selective Thiophene-Based K V 1.3 Inhibitors and Their Potential for Anticancer Activity. Cancers 2022, 14 , 2595. Cancers 15 (11) (2023)
Špela Gubič, Louise Antonia Hendrickx, Xiaoyi Shi, Žan Toplak, Štefan Možina, Kenny M Van Theemsche, Ernesto Lopes Pinheiro-Junior, Steve Peigneur, Alain J Labro, Luis A Pardo, Jan Tytgat, Tihomir Tomašič, Lucija Peterlin Mašič
Design of New Potent and Selective Thiophene-Based K V 1.3 Inhibitors and Their Potential for Anticancer Activity. Cancers 14 (11) (2022)
Špela Gubič, Žan Toplak, Xiaoyi Shi, Jaka Dernovšek, Louise Antonia Hendrickx, Ernesto Lopes Pinheiro-Junior, Steve Peigneur, Jan Tytgat, Luis A Pardo, Lucija Peterlin Mašič, Tihomir Tomašič
New Diarylamine K V 10.1 Inhibitors and Their Anticancer Potential. Pharmaceutics 14 (9) (2022)
Špela Gubič, Louise A Hendrickx, Žan Toplak, Maša Sterle, Steve Peigneur, Tihomir Tomašič, Luis A Pardo, Jan Tytgat, Anamarija Zega, Lucija Peterlin Mašič
Discovery of KV 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges. Medicinal research reviews 41 (4) (2021)